肝细胞不典型增生合并布加综合征误诊为肝细胞癌1例报告

庞润华; 朱亚青

doi:10.3969/j.issn.1001-5256.2020.05.033

肝细胞不典型增生合并布加综合征误诊为肝细胞癌1例报告

DOI: 10.3969/j.issn.1001-5256.2020.05.033

广州中医药大学第一附属医院三外科

详细信息

中图分类号: R575
计量
- 文章访问数: 685
- HTML全文浏览量: 7
- PDF下载量: 118
- 被引次数: 0
出版历程
- 出版日期: 2020-05-20

Hepatic dysplastic nodules with Budd-Chiari syndrome misdiagnosed as hepatocellular carcinoma: A case report

The Third Department of surgery, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510405, China

摘要

摘要:
<正>肝脏不典型增生结节（hepatic dysplastic nodules,HDN）,也称为异型增生结节,为肝硬化背景上边界相对清楚的结节样占位性病变。现将1例HDN合并布加综合征（Budd-Chiari syn-drome,BCS）被误诊为肝细胞癌（HCC）患者报道如下。1病例资料患者男性,34岁,因"发现黄疸1个月余"于2019年5月13
- 肝脏不典型增生结节 /
- Budd-Chiari综合征 /
- 癌,肝细胞
- hepatic dysplastic nodules /
- Budd-Chiari syndrome /
- carcinoma,hepatocellular

HTML全文

参考文献(14)

[1] VILLANUEVA A. Hepatocellular carcinoma[J]. N Engl J Med,2019, 380(15):1450-1462.

[2] RICH NE, HESTER C, ODEWOLE M, et al. Racial and ethnic differences in presentation and outcomes of hepatocellular carcinoma[J]. Clin Gastroenterol Hepatol, 2019, 17(3):551-559.

[3] LLOVET JM, MONTAL R, SIA D, et al. Molecular therapies and precision medicine for hepatocellular carcinoma[J]. Nat Rev Clin Oncol, 2018, 15(10):599-616.

[4] SIM HW, KNOX J. Hepatocellular carcinoma in the era of immunotherapy[J]. Curr Probl Cancer, 2018, 42(1):40-48.

[5] CHOI JY, LEE JM, SIRLIN CB. CT and MR imaging diagnosis and staging of hepatocellular carcinoma:Part II. Extracellular agents, hepatobiliary agents, and ancillary imaging features[J]. Radiology, 2014, 273(1):30-50.

[6] ICHIKAWA T, SANO K, MORISAKA H. Diagnosis of pathologically early HCC with EOB-MRI:Experiences and current consensus[J]. Liver Cancer, 2014, 3(2):97-107.

[7] CHOU CT, CHOU JM, CHANG TA, et al. Differentiation between dysplastic nodule and early-stage hepatocellular carcinoma:The utility of conventional MR imaging[J]. World J Gastroenterol, 2013, 19(42):7433-7439.

[8] MATSUI O, KOBAYASHI S, SANADA J, et al. Hepatocelluar nodules in liver cirrhosis:Hemodynamic evaluation(angiography-assisted CT)with special reference to multi-step hepatocarcinogenesis[J]. Abdom Imaging, 2011, 36(3):264-272.

[9] MARTENS P, NEVENS F. Budd-Chiari syndrome[J]. United European Gastroenterol J, 2015, 3(6):489-500.

[10] BANSAL V, GUPTA P, SINHA S, et al. Budd-Chiari syndrome:Imaging review[J]. Br J Radiol, 2018, 91(1092):20180441.

[11] EAPEN CE, VELISSARIS D, HEYDTMANN M, et al. Favourable medium term outcome following hepatic vein recanalisation and/or transjugular intrahepatic portosystemic shunt for Budd Chiari syndrome[J]. Gut, 2006, 55(6):878-884.

[12] VALLA DC. Budd-Chiari syndrome/hepatic venous outflow tract obstruction[J]. Hepatol Int, 2018, 12(Suppl 1):168-180.

[13] CHANG XJ, LI YY, YANG B, et al. Association of biological characteristics of hepatitis B virus with the progression of liver fibrosis[J]. J Clin Hepatol, 2019, 35(8):1834-1837.(in Chinese）常秀娟，李因茵，杨斌，等．HBV生物学特性与肝纤维化进展的关系[J]．临床肝胆病杂志，2019, 35(8):1834-1837.

[14] CHEN YP. Advances in the diagnosis and treatment of noncirrhotic sinusoidal portal hypertension[J]. J Clin Hepatol,2019, 35(1):18-22.(in Chinese）陈永鹏．肝硬化以外窦性门静脉高压症的诊断与治疗[J]．临床肝胆病杂志，2019, 35(1):18-22.

施引文献

资源附件(0)

访问统计